You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GYRE Award Disclosure
Epstein David M. · SEC Form 4 · Filed Jun 30, 2026
Award
Calculated transaction value
$0
Epstein David M. Director
GYRE
Gyre Therapeutics
GYRE
Transaction date
Jun 10, 2026
Public filing date
Jun 30, 2026
Filing lag
Filed 20 days later
GYRE daily price context
Close on/before transaction
$5.95
Jun 10, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 40,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001140361-26-027007
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Gyre Therapeutics, Inc. GYRE Current | Award | Jun 10, 2026 | $0 |